172 related articles for article (PubMed ID: 11961131)
1. Five amino acids of the Xenopus laevis CRF (corticotropin-releasing factor) type 2 receptor mediate differential binding of CRF ligands in comparison with its human counterpart.
Dautzenberg FM; Higelin J; Brauns O; Butscha B; Hauger RL
Mol Pharmacol; 2002 May; 61(5):1132-9. PubMed ID: 11961131
[TBL] [Abstract][Full Text] [Related]
2. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
Dautzenberg FM; Wille S
Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
[TBL] [Abstract][Full Text] [Related]
3. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site.
Dautzenberg FM; Wille S; Lohmann R; Spiess J
Proc Natl Acad Sci U S A; 1998 Apr; 95(9):4941-6. PubMed ID: 9560207
[TBL] [Abstract][Full Text] [Related]
4. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
Dautzenberg FM; Py-Lang G; Higelin J; Fischer C; Wright MB; Huber G
J Pharmacol Exp Ther; 2001 Jan; 296(1):113-20. PubMed ID: 11123370
[TBL] [Abstract][Full Text] [Related]
5. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding.
Wille S; Sydow S; Palchaudhuri MR; Spiess J; Dautzenberg FM
J Neurochem; 1999 Jan; 72(1):388-95. PubMed ID: 9886092
[TBL] [Abstract][Full Text] [Related]
6. 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors.
Higelin J; Py-Lang G; Paternoster C; Ellis GJ; Patel A; Dautzenberg FM
Neuropharmacology; 2001; 40(1):114-22. PubMed ID: 11077077
[TBL] [Abstract][Full Text] [Related]
7. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor.
Dautzenberg FM; Dietrich K; Palchaudhuri MR; Spiess J
J Neurochem; 1997 Oct; 69(4):1640-9. PubMed ID: 9326293
[TBL] [Abstract][Full Text] [Related]
8. The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.
Dautzenberg FM; Kilpatrick GJ; Wille S; Hauger RL
J Neurochem; 1999 Aug; 73(2):821-9. PubMed ID: 10428081
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the abundant expression of arginine 185 containing human CRF(2alpha) receptors and the role of position 185 for receptor-ligand selectivity.
Dautzenberg FM; Huber G; Higelin J; Py-Lang G; Kilpatrick GJ
Neuropharmacology; 2000 Jun; 39(8):1368-76. PubMed ID: 10818253
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the ovine type 1 corticotropin releasing factor receptor (CRF1) and a carboxyl-terminal variant.
Myers DA; Trinh JV; Myers TR
Mol Cell Endocrinol; 1998 Sep; 144(1-2):21-35. PubMed ID: 9863624
[TBL] [Abstract][Full Text] [Related]
11. Ligand requirements of the human corticotropin-releasing factor-binding protein.
Sutton SW; Behan DP; Lahrichi SL; Kaiser R; Corrigan A; Lowry P; Potter E; Perrin MH; Rivier J; Vale WW
Endocrinology; 1995 Mar; 136(3):1097-102. PubMed ID: 7867564
[TBL] [Abstract][Full Text] [Related]
12. A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.
Eckart K; Jahn O; Radulovic J; Tezval H; van Werven L; Spiess J
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11142-7. PubMed ID: 11572971
[TBL] [Abstract][Full Text] [Related]
13. Cloning and functional pharmacology of two corticotropin-releasing factor receptors from a teleost fish.
Pohl S; Darlison MG; Clarke WC; Lederis K; Richter D
Eur J Pharmacol; 2001 Nov; 430(2-3):193-202. PubMed ID: 11711031
[TBL] [Abstract][Full Text] [Related]
14. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor.
Xiong Y; Xie LY; Abou-Samra AB
Endocrinology; 1995 May; 136(5):1828-34. PubMed ID: 7720627
[TBL] [Abstract][Full Text] [Related]
15. The first extracellular domain of corticotropin releasing factor-R1 contains major binding determinants for urocortin and astressin.
Perrin MH; Sutton S; Bain DL; Berggren WT; Vale WW
Endocrinology; 1998 Feb; 139(2):566-70. PubMed ID: 9449626
[TBL] [Abstract][Full Text] [Related]
16. [¹²⁵I]YP20: a novel radioligand specific for the extracellular domain of the CRF₁ receptor.
Gordon JC; Edwards P; Elmore CS; Lazor LA; Paschetto K; Bostwick R; Sylvester M; Mauger R; Scott C; Aharony D
Eur J Pharmacol; 2010 Dec; 649(1-3):59-63. PubMed ID: 20854803
[TBL] [Abstract][Full Text] [Related]
17. The alternatively spliced type II corticotropin-releasing factor receptor, stably expressed in LLCPK-1 cells, is not well coupled to the G protein(s).
Nabhan C; Xiong Y; Xie LY; Abou-Samra AB
Biochem Biophys Res Commun; 1995 Jul; 212(3):1015-21. PubMed ID: 7626087
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution.
Palchaudhuri MR; Wille S; Mevenkamp G; Spiess J; Fuchs E; Dautzenberg FM
Eur J Biochem; 1998 Nov; 258(1):78-84. PubMed ID: 9851694
[TBL] [Abstract][Full Text] [Related]
19. The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding.
Sydow S; Flaccus A; Fischer A; Spiess J
Eur J Biochem; 1999 Jan; 259(1-2):55-62. PubMed ID: 9914475
[TBL] [Abstract][Full Text] [Related]
20. Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity.
Hoare SR; Sullivan SK; Fan J; Khongsaly K; Grigoriadis DE
Peptides; 2005 Mar; 26(3):457-70. PubMed ID: 15652653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]